Associations between different measurements of sarcopenic obesity and health outcomes among non-frail community-dwelling older adults in Taiwan

Br J Nutr. 2021 Apr 14:1-34. doi: 10.1017/S0007114521001288. Online ahead of print.ABSTRACTThe most important issue for the clinical application of sarcopenic obesity is the lack of a consensus definition. The aim of this study was to determine the best measurement for sarcopenic obesity by estimating the association between various definitions and the risk of falls and metabolic syndrome.We studied a community of 765 adults aged 65 and older in 2015-2017. Sarcopenia obesity was measured by sarcopenia (defined by low muscle mass with either low handgrip strength or low gait speed or both) plus obesity (defined by waist circumference, body fat percentage, and BMI). Metabolic syndrome was defined according to the National Cholesterol Education Program ATP III. Logistic regression models were constructed to examine the relationships between sarcopenia obesity and risk of fall and metabolic syndrome. In the analysis of the fall risk with sarcopenic obesity defined by waist circumference, the participants with nonsarcopenia/nonobesity were treated as the reference group. The odds ratio to fall in participants with sarcopenic obesity was 10.16 (95% CI, 2.71-38.13) after adjusting for confounding covariates. In the analysis of the risk of metabolic syndrome between participants with individual components of sarcopenia coupled with obesity defined by waist circumference, the risk was statistically significant for low gait speed (OR: 7.19; 95% 3.61-14.30) and low grip strength (OR: 9....
Source: The British Journal of Nutrition - Category: Nutrition Authors: Source Type: research